Total and Amyris
to build a strategic partnership for biomass-based fuels and chemicals
Emeryville, California, USA and Paris, France, June 23, 2010 — Total, a major international oil
and gas company, and Amyris Inc., which operates an industrial synthetic biology platform,
announced today a strategic partnership encompassing Total’s investment in Amyris and a wide-
spectrum master development and collaboration agreement.
Total has agreed to acquire approximately 17% equity interest in Amyris on a fully diluted basis,
and will have the right to appoint a member of the Amyris Board of Directors.
Under their collaboration agreement, Total and Amyris R&D teams will work together to develop
new products and build biological pathways to produce and commercialize renewable fuels and
The partnership combines Amyris’ industrial synthetic biology platform and emerging Brazilian
production capacity with Total’s technological know-how, industrial scale-up capabilities and
access to markets.
“Biotechnology offers new perspectives on the conversion of biomass into molecules for biofuels
and green chemistry,” emphasized Philippe Boisseau, President, Total Gas & Power. “ Amyris is
one of the most promising start-ups in the emerging white biotechnology field. Its technology
platform is a powerful accelerator for the development of industrial production routes for several
of our markets. This partnership is a milestone for Total, as we aim to become an important
player in this domain.”
“Our partnership with Total represents a significant shift forward for Amyris,” said John Melo, Chief
Executive Officer of Amyris. “Through our existing relationships and accomplishments, we have
built Amyris to be an integrated renewable products company combining technology, production
and commercialization. Now, with Total, we have a powerful ally to help us bring that vision to
scale and expand our horizons to new products and new technologies.”